Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PYXS
$3.24
+0.31%
PYXS
· Pyxis Oncology, Inc.
$3.24
+0.01 (+0.31%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$269.41M
Shares
83.41M
All earnings calls
Earnings call · FY2025 Q2
Pyxis Oncology, Inc. (PYXS) Q2 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$2.82M
Diluted EPS
-$0.30
Net income
-$18.35M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2025 · complete as-filed document